Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 5, 2005, Pages 485-490

  Morikawa, Keiko ^a   Matoba, Tetsuya ^a   Kubota, Hiroshi ^a   Hatanaka, Makoto ^a   Fujiki, Takako ^a   Takahashi, Shosuke ^a   Takeshita, Akira ^a   Shimokawa, Hiroaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Endothelium; Endothelium derived hyperpolarizing factor; Hypercholesterolemia; Membrane potential

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; CHOLESTEROL; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUCOSE; INDOMETACIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SENSITIVITY; ENDOTHELIUM; HYPERCHOLESTEROLEMIA; MEMBRANE POTENTIAL; MESENTERIC ARTERY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; VASODILATATION;

ACETYLCHOLINE; ANIMALS; APOLIPOPROTEINS E; BENZIMIDAZOLES; BIOLOGICAL FACTORS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HYPERCHOLESTEROLEMIA; LIPIDS; MEMBRANE POTENTIALS; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITROPRUSSIDE; POTASSIUM CHANNELS; VASODILATION; VASODILATOR AGENTS;

EID: 18244391983     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000159657.93922.cb     Document Type: Article

References (34)

1. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol. 1999;31:23-37.
2. Fisslthaler B, Popp R, Kiss L, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497.
3. Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res. 2004;49:525-533.
4. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;396:269-272.
5. Edwards G, Weston AH. Potassium and potassium clouds in endothelium-dependent hyperpolarizations. Pharmacol Res. 2004;49:535-541.
6. Taylor HJ, Chaytor AT, Evans WH, et al. Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-alpha glycyrrhetinic acid. Br J Pharmacol. 1998;125:1-3.
7. Griffith TM, Chaytor AT, Edwards DH. The obligatory link: role of gap junctional communication in endothelium-dependent smooth muscle hyperpolarization. Pharmacol Res. 2004;49:551-564.
8. Matoba T, Shimokawa H, Nakashima M, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizinn factor in mice. J Clin Invest. 2000; 106:1521-1530.
9. Matoba T, Shimokawa H, Kubota H, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun. 2002;290:909-913.
10. Shimokawa H, Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol Res. 2004;49:543-549.
11. Matoba T, Shimokawa H, Morikawa K, et al. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol. 2003;23:1224-1230.
12. Vanhoutte PM. Endothelium-dependent hyperpolarizations: the history. Pharmacol Res. 2004;49:503-508.
13. Shimokawa H, Yasutake H, Fujii K, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol. 1996;28:703-711.
14. Urakami-Harasawa L, Shimokawa H, Nakashima M, et al. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest. 1997;100:2793-2799.
15. De Vriese AS, Verbeuren TJ, Van de Voorde J, et al. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-974.
16. d'Useio LV, Smith LA, Katusic ZS. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. Stroke. 2001;32:2658-2664.
17. Feletou M, Vanhoutte PM. EDHF: new therapeutic targets? Pharmacol Res. 2004;49:565-580.
18. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes. 2001;50:2114-2125.
19. Fukao M, Hattori Y, Kanno M, et al. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol. 1997;121:1383-1391.
20. Morikawa K, Shimokawa H, Matoba T, et al. Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest. 2003;112:1871-1879.
21. Zygmunt PM, Plane F, Paulsson M, et al. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF. Br J Pharmacol. 1998;124:992-1000.
22. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension. 1998;31:1047-1060.
23. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001:88:E14-E22.
24. Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest. 2002;109:817-826.
25. Alp NJ, Mussa S, Khoo J, et al. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase 1 overexpression. J Clin Invest. 2003;112:725-735.
26. Makino A, Ohuchi K, Kamata K. Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br J Pharmacol. 2000;130:549-556.
27. Terata K, Coppey LJ, Davidson EP, et al. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br J Pharmacol. 1999;128:837-843.
28. De Vriese AS, Van de Voorde J, Blom HJ, et al. The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate. Diabetologia. 2000;43:1116-1125.
29. Vasquez-Vivar J, Martasek P, Whitsett J, et al. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J. 2002;362:733-739.
30. Adachi T, Weisbrod RM, Pimentel DR, et al. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med. 2004;10:1200-1207.
31. Laursen JB, Somers M, Kurz S, et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 2001;103:1282-1288.
32. Mullen MJ, Kharbanda RK, Cross J, et al. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res. 2001;88:145-151.
33. Brandes RP, Behra A, Lebherz C, et al. N(G)-Nitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis. 1997;135: 49-55.
34. Kagota S, Tamashiro A, Yamaguchi Y, et al. Excessive salt or cholesterol intake alters the balance among endothelium-derived factors released from renal arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1999;34:533-539.